Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against

David H. Epstein, K. L. Preston

Research output: Contribution to journalArticle

Abstract

Aims: To determine whether cannabinoid-positive urine specimens in heroin-dependent out-patients predict other drug use or impairments in psychosocial functioning, and whether such outcomes are better predicted by cannabis-use disorders than by cannabis use itself. Design: Retrospective analyses of three clinical trials; each included a behavioral intervention (contingency management) for cocaine or heroin use during methadone maintenance. Trials lasted 25-29 weeks; follow-up evaluations occurred 3, 6 and 12 months post-treatment. For the present analyses, data were pooled across trials where appropriate. Setting: Urban out-patient methadone clinic. Participants: Four hundred and eight polydrug abusers meeting methadone-maintenance criteria. Measurements: Participants were categorized as non-users, occasional users or frequent users of cannabis based on thrice-weekly qualitative urinalyses. Cannabis-use disorders were assessed with the Diagnostic Interview Schedule III-R. Outcome measures included proportion of cocaine- and opiate-positive urines and the Addiction Severity Index (at intake and follow-ups). Findings: Cannabis use was not associated with retention, use of cocaine or heroin, or any other outcome measure during or after treatment. Our analyses had a power of 0.95 to detect an r2 of 0.11 between cannabis use and heroin or cocaine use: the r2 we detected was less than 0.03 and non-significant. A previous finding, that cannabis use predicted lapse to heroin use in heroin-abstinent patients, did not replicate in our sample. However, cannabis-use disorders were associated weakly with psychosocial problems at post-treatment follow-up. Conclusions: Cannabinoid-positive urines need not be a major focus of clinical attention during treatment for opiate dependence, unless patients report symptoms of cannabis-use disorders.

Original languageEnglish (US)
Pages (from-to)269-279
Number of pages11
JournalAddiction
Volume98
Issue number3
DOIs
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Heroin
Cannabis
Cocaine
Methadone
Therapeutics
Cannabinoids
Urine
Opiate Alkaloids
Outpatients
Outcome Assessment (Health Care)
Opioid-Related Disorders
Urinalysis
Appointments and Schedules
Maintenance
Clinical Trials
Interviews

Keywords

  • Cannabis
  • Methadone maintenance
  • Treatment outcome

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. / Epstein, David H.; Preston, K. L.

In: Addiction, Vol. 98, No. 3, 01.03.2003, p. 269-279.

Research output: Contribution to journalArticle

@article{fb3938ae016b485aa85fa51bc3d3a58e,
title = "Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against",
abstract = "Aims: To determine whether cannabinoid-positive urine specimens in heroin-dependent out-patients predict other drug use or impairments in psychosocial functioning, and whether such outcomes are better predicted by cannabis-use disorders than by cannabis use itself. Design: Retrospective analyses of three clinical trials; each included a behavioral intervention (contingency management) for cocaine or heroin use during methadone maintenance. Trials lasted 25-29 weeks; follow-up evaluations occurred 3, 6 and 12 months post-treatment. For the present analyses, data were pooled across trials where appropriate. Setting: Urban out-patient methadone clinic. Participants: Four hundred and eight polydrug abusers meeting methadone-maintenance criteria. Measurements: Participants were categorized as non-users, occasional users or frequent users of cannabis based on thrice-weekly qualitative urinalyses. Cannabis-use disorders were assessed with the Diagnostic Interview Schedule III-R. Outcome measures included proportion of cocaine- and opiate-positive urines and the Addiction Severity Index (at intake and follow-ups). Findings: Cannabis use was not associated with retention, use of cocaine or heroin, or any other outcome measure during or after treatment. Our analyses had a power of 0.95 to detect an r2 of 0.11 between cannabis use and heroin or cocaine use: the r2 we detected was less than 0.03 and non-significant. A previous finding, that cannabis use predicted lapse to heroin use in heroin-abstinent patients, did not replicate in our sample. However, cannabis-use disorders were associated weakly with psychosocial problems at post-treatment follow-up. Conclusions: Cannabinoid-positive urines need not be a major focus of clinical attention during treatment for opiate dependence, unless patients report symptoms of cannabis-use disorders.",
keywords = "Cannabis, Methadone maintenance, Treatment outcome",
author = "Epstein, {David H.} and Preston, {K. L.}",
year = "2003",
month = "3",
day = "1",
doi = "10.1046/j.1360-0443.2003.00310.x",
language = "English (US)",
volume = "98",
pages = "269--279",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against

AU - Epstein, David H.

AU - Preston, K. L.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Aims: To determine whether cannabinoid-positive urine specimens in heroin-dependent out-patients predict other drug use or impairments in psychosocial functioning, and whether such outcomes are better predicted by cannabis-use disorders than by cannabis use itself. Design: Retrospective analyses of three clinical trials; each included a behavioral intervention (contingency management) for cocaine or heroin use during methadone maintenance. Trials lasted 25-29 weeks; follow-up evaluations occurred 3, 6 and 12 months post-treatment. For the present analyses, data were pooled across trials where appropriate. Setting: Urban out-patient methadone clinic. Participants: Four hundred and eight polydrug abusers meeting methadone-maintenance criteria. Measurements: Participants were categorized as non-users, occasional users or frequent users of cannabis based on thrice-weekly qualitative urinalyses. Cannabis-use disorders were assessed with the Diagnostic Interview Schedule III-R. Outcome measures included proportion of cocaine- and opiate-positive urines and the Addiction Severity Index (at intake and follow-ups). Findings: Cannabis use was not associated with retention, use of cocaine or heroin, or any other outcome measure during or after treatment. Our analyses had a power of 0.95 to detect an r2 of 0.11 between cannabis use and heroin or cocaine use: the r2 we detected was less than 0.03 and non-significant. A previous finding, that cannabis use predicted lapse to heroin use in heroin-abstinent patients, did not replicate in our sample. However, cannabis-use disorders were associated weakly with psychosocial problems at post-treatment follow-up. Conclusions: Cannabinoid-positive urines need not be a major focus of clinical attention during treatment for opiate dependence, unless patients report symptoms of cannabis-use disorders.

AB - Aims: To determine whether cannabinoid-positive urine specimens in heroin-dependent out-patients predict other drug use or impairments in psychosocial functioning, and whether such outcomes are better predicted by cannabis-use disorders than by cannabis use itself. Design: Retrospective analyses of three clinical trials; each included a behavioral intervention (contingency management) for cocaine or heroin use during methadone maintenance. Trials lasted 25-29 weeks; follow-up evaluations occurred 3, 6 and 12 months post-treatment. For the present analyses, data were pooled across trials where appropriate. Setting: Urban out-patient methadone clinic. Participants: Four hundred and eight polydrug abusers meeting methadone-maintenance criteria. Measurements: Participants were categorized as non-users, occasional users or frequent users of cannabis based on thrice-weekly qualitative urinalyses. Cannabis-use disorders were assessed with the Diagnostic Interview Schedule III-R. Outcome measures included proportion of cocaine- and opiate-positive urines and the Addiction Severity Index (at intake and follow-ups). Findings: Cannabis use was not associated with retention, use of cocaine or heroin, or any other outcome measure during or after treatment. Our analyses had a power of 0.95 to detect an r2 of 0.11 between cannabis use and heroin or cocaine use: the r2 we detected was less than 0.03 and non-significant. A previous finding, that cannabis use predicted lapse to heroin use in heroin-abstinent patients, did not replicate in our sample. However, cannabis-use disorders were associated weakly with psychosocial problems at post-treatment follow-up. Conclusions: Cannabinoid-positive urines need not be a major focus of clinical attention during treatment for opiate dependence, unless patients report symptoms of cannabis-use disorders.

KW - Cannabis

KW - Methadone maintenance

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=0037373599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037373599&partnerID=8YFLogxK

U2 - 10.1046/j.1360-0443.2003.00310.x

DO - 10.1046/j.1360-0443.2003.00310.x

M3 - Article

VL - 98

SP - 269

EP - 279

JO - Addiction

JF - Addiction

SN - 0965-2140

IS - 3

ER -